Position in ALVO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$81,743
+$2,439 QoQ
Shares Held
23,832
+54.2% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026BARCLAYS PLC holds $516,666,064 across 52 Drug Manufacturers - Specialty & Generic names. ALVO ranks #41 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,809,925 | $213,951,231 | |
| 2 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,745,751 | $53,210,488 | |
| 3 | VTRS |
Viatris Inc
|
3,144,439 | $42,481,369 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,400,671 | $42,188,210 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
63,005 | $37,360,703 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
243,984 | $32,142,450 | |
| 7 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
971,854 | $13,508,770 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
639,372 | $13,273,362 |
All Filings in ALVO
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $81,743 | 23,832 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $79,304 | 15,459 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $173,660 | 21,204 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $191,738 | 21,024 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $219,189 | 22,667 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $209,827 | 15,860 | Shares | Sole | 2025-02-13 | |
| 2022-06-30 | $10,311 | 1,256 | Shares | Sole | 2022-08-12 | |
| No filing history on record for this holder in this stock. | ||||||